Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs
- 1 February 1995
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 345 (8946) , 365-369
- https://doi.org/10.1016/s0140-6736(95)90346-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hepatitis C virus transmission by intravenous immunoglobulinJournal of Hepatology, 1994
- Rapid subcutaneous immunoglobulin infusions in childrenThe Lancet, 1993
- The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusionsClinical and Experimental Immunology, 1993
- Itching for an explanationTrends in Neurosciences, 1992
- Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusionThe Lancet, 1991
- Prophylactic effect of self-administered pump-driven subcutaneous IgG infusion in patients with antibody deficiency: a triple-blind cross-over study comparing P-IgG levels of 3 g l−1versus 6 g l−1Journal of Internal Medicine, 1991
- Intravenous Immune Globulin and Acute Aseptic MeningitisNew England Journal of Medicine, 1990
- SUBCUTANEOUS IMMUNOGLOBULIN HOME TREATMENT IN HYPOGAMMAGLOBULINAEMIAThe Lancet, 1986
- Home intravenous immunoglobulin therapy by self-administrationJournal of Clinical Immunology, 1986
- SUBCUTANEOUS INFUSION OF GAMMAGLOBULINS IN MANAGEMENT OF AGAMMAGLOBULINAEMIAThe Lancet, 1982